InvestorsObserver
×
News Home

NGM Biopharmaceuticals Inc (NGM) Stock Gains 12.15% This Week: Is It a Good Pick?

Monday, October 02, 2023 10:24 AM | InvestorsObserver Analysts

Mentioned in this article

NGM Biopharmaceuticals Inc (NGM) Stock  Gains 12.15% This Week: Is It a Good Pick?

NGM Biopharmaceuticals Inc (NGM) stock is down -90.53% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives NGM stock a score of 33 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 1. NGM's rank also includes a long-term technical score of 3.
Overall Score - 33
NGM has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on NGM!

What's Happening with NGM Stock Today

NGM Biopharmaceuticals Inc (NGM) stock is up 12.15% while the S&P 500 is down -0.03% as of 10:23 AM on Monday, Oct 2. NGM has risen $0.13 from the previous closing price of $1.07 on volume of 279,250 shares. Over the past year the S&P 500 is higher by 16.53% while NGM is down -90.53%. NGM lost -$2.08 per share in the over the last 12 months. Click Here to get the full Stock Report for NGM Biopharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App